NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
1.400
0.00 (0.00%)
At close: Sep 8, 2026, 4:00 PM EDT
1.400
0.00 (0.00%)
After-hours: Sep 8, 2026, 4:10 PM EDT
NuCana Market Cap
NuCana has a market cap or net worth of $6.03 million as of September 8, 2026. Its market cap has increased by 4.02% in one year.
Market Cap
6.03M
Enterprise Value
-18.95M
1-Year Change
4.02%
Ranking
Category
Stock Price
$1.40
ChartMarket Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $6.03M, a decrease of -98.83%. That is a compound annual growth rate of -39.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 5.80M | -61.33% |
| Dec 31, 2025 | 15.00M | 219.15% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
| Sep 28, 2017 | 513.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AIM ImmunoTech | 6.93M |
| CollPlant Biotechnologies | 6.71M |
| GRI Bio | 6.30M |
| Kairos Pharma | 6.23M |
| Enveric Biosciences | 6.22M |
| Purple Biotech | 6.19M |
| XTL Biopharmaceuticals | 5.88M |
| Processa Pharmaceuticals | 5.75M |